Comparison of [111In]pentetreotide‐SPECT and [18F]FDOPA‐PET in the localization of extra‐adrenal paragangliomas: the case for a patient‐tailored use of nuclear imaging modalities
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Clinical endocrinology |
| Beteiligte Personen: |
Charrier, N. [VerfasserIn] |
|---|
| BKL: |
|---|
| RVK: |
|---|
| Umfang: |
9 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC185523694X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC185523694X | ||
| 003 | DE-627 | ||
| 005 | 20230516130042.0 | ||
| 007 | tu | ||
| 008 | 110103s2011 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw101231_1 |
| 035 | |a (DE-627)OLC185523694X | ||
| 035 | |a (DE-599)GBVOLC185523694X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.89 |2 bkl | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Charrier, N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of [111In]pentetreotide‐SPECT and [18F]FDOPA‐PET in the localization of extra‐adrenal paragangliomas: the case for a patient‐tailored use of nuclear imaging modalities |
| 264 | 1 | |c 2011 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Deveze, A. |4 oth | |
| 700 | 1 | |a Fakhry, N. |4 oth | |
| 700 | 1 | |a Sebag, F. |4 oth | |
| 700 | 1 | |a Morange, I. |4 oth | |
| 700 | 1 | |a Gaborit, B. |4 oth | |
| 700 | 1 | |a Barlier, A. |4 oth | |
| 700 | 1 | |a Carmona, E. |4 oth | |
| 700 | 1 | |a De Micco, C. |4 oth | |
| 700 | 1 | |a Garcia, S. |4 oth | |
| 700 | 1 | |a Mancini, J. |4 oth | |
| 700 | 1 | |a Palazzo, F. F. |4 oth | |
| 700 | 1 | |a Lavieille, J. P. |4 oth | |
| 700 | 1 | |a Zanaret, M. |4 oth | |
| 700 | 1 | |a Henry, J. F. |4 oth | |
| 700 | 1 | |a Mundler, O. |4 oth | |
| 700 | 1 | |a Taïeb, D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endocrinology <Oxford> |d Oxford [u.a.] : Wiley-Blackwell, 1972 |g 74(2011), 1 vom: Jan., Seite 21-30 |w (DE-627)129299251 |w (DE-600)121745-8 |w (DE-576)014492032 |x 0300-0664 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2011 |g number:1 |g month:01 |g pages:21-30 |g extent:9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.89 |q AVZ |
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 74 |j 2011 |e 1 |c 1 |h 21-30 |g 9 | ||